deltatrials
Completed NA NCT00139893

A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis

Sponsor: UCB Pharma

Conditions Diabetic Gastroparesis
Interventions Reglan ODT
Updated 5 times since 2017 Last updated: Mar 25, 2013 Started: Jun 30, 2005 Primary completion: Oct 31, 2005

This NA trial investigates Diabetic Gastroparesis and is currently completed. UCB Pharma leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • UCB Pharma
Data source: UCB Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Milwaukee, United States